Total Payments
$1,138
2024 Payments
$497.82
Companies
19
Transactions
35
Medicare Patients
2,143
Medicare Billing
$161,388
Payment Breakdown by Category
Food & Beverage$998.03 (87.7%)
Education$140.09 (12.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $998.03 | 32 | 87.7% |
| Education | $140.09 | 3 | 12.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $182.93 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $172.30 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $171.59 | 2 | $0 (2024) |
| PFIZER INC. | $78.10 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $76.31 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $75.37 | 2 | $0 (2024) |
| Exelixis Inc. | $62.82 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $49.60 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $45.38 | 2 | $0 (2024) |
| ARRAY BIOPHARMA INC | $34.99 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $497.82 | 22 | Merck Sharp & Dohme LLC ($56.95) |
| 2023 | $81.56 | 4 | Eisai Inc. ($23.44) |
| 2022 | $26.10 | 1 | PFIZER INC. ($26.10) |
| 2021 | $261.46 | 2 | E.R. Squibb & Sons, L.L.C. ($153.04) |
| 2020 | $14.65 | 1 | PFIZER INC. ($14.65) |
| 2019 | $104.53 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($43.89) |
| 2018 | $152.00 | 2 | AstraZeneca Pharmaceuticals LP ($127.70) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.55 | General |
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Oncology | ||||||
| 09/18/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Genentech USA, Inc. | Polivy (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: BioOncology | ||||||
| 06/26/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, TECVAYLI | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Oncology | ||||||
| 05/08/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 04/18/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.92 | General |
| Category: Hematology | ||||||
| 02/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: ONCOLOGY | ||||||
| 01/04/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Oncology | ||||||
| 12/05/2023 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: Oncology | ||||||
| 08/09/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 449 | 735 | $165,432 | $39,055 |
| 2022 | 9 | 524 | 792 | $167,463 | $37,807 |
| 2021 | 10 | 588 | 848 | $191,435 | $44,708 |
| 2020 | 10 | 582 | 901 | $192,248 | $39,818 |
Total Patients
2,143
Total Services
3,276
Medicare Billing
$161,388
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 206 | 382 | $81,366 | $18,450 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 104 | $32,656 | $7,730 | 23.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 93 | $19,530 | $5,764 | 29.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 82 | $10,578 | $1,936 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,776 | $1,493 | 22.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $5,600 | $1,463 | 26.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 28 | $3,220 | $1,117 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $5,706 | $1,104 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 188 | 340 | $72,420 | $16,147 | 22.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 132 | 183 | $23,607 | $4,505 | 19.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 72 | $15,120 | $4,072 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 46 | $14,444 | $3,503 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $13,314 | $2,588 | 19.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 37 | 59 | $6,785 | $1,822 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $7,813 | $1,764 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $7,744 | $1,728 | 22.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 20 | 21 | $6,216 | $1,677 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 179 | 306 | $65,178 | $14,965 | 23.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 51 | 92 | $19,320 | $5,308 | 27.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 66 | $20,724 | $4,709 | 22.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 122 | 165 | $21,285 | $4,506 | 21.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $18,876 | $4,007 | 21.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 34 | 34 | $10,064 | $2,753 | 27.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 53 | 80 | $9,200 | $2,466 | 26.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 18 | $7,596 | $2,139 | 28.2% |
About Dr. Lynn Zemsky, MD
Dr. Lynn Zemsky, MD is a Hematology & Oncology healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922086412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lynn Zemsky, MD has received a total of $1,138 in payments from pharmaceutical and medical device companies, with $497.82 received in 2024. These payments were reported across 35 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($998.03).
As a Medicare-enrolled provider, Zemsky has provided services to 2,143 Medicare beneficiaries, totaling 3,276 services with total Medicare billing of $161,388. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Marietta, GA
- Active Since 01/04/2006
- Last Updated 11/23/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1922086412
Products in Payments
- OPDIVO (Biological) $153.04
- TAGRISSO (Drug) $127.70
- CYRAMZA (Drug) $108.42
- KEYTRUDA (Biological) $76.31
- VERZENIO (Drug) $74.51
- DARZALEX (Biological) $45.38
- LYNPARZA (Drug) $44.60
- NINLARO (Drug) $43.89
- Cabometyx (Drug) $41.28
- BRAFTOVI (Drug) $34.99
- SCEMBLIX (Drug) $31.62
- ALUNBRIG (Drug) $31.48
- JEMPERLI (Biological) $29.37
- PREVNAR 20 (Biological) $26.10
- Polivy (Biological) $23.71
- Lenvima (Drug) $23.44
- REBLOZYL (Biological) $21.92
- CABOMETYX (Drug) $21.54
- BELEODAQ (Drug) $21.12
- OJJAARA (Drug) $20.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Marietta
Dr. Steven Mccune, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $492,856
Hematology & Oncology $492,856
Dr. Gena Volas-Redd, Md, MD
Hematology & Oncology — Payments: $115,709
Hematology & Oncology $115,709
Dr. John French, Md, MD
Hematology & Oncology — Payments: $70,611
Hematology & Oncology $70,611
Dr. Louis Garrot, M.d, M.D
Hematology & Oncology — Payments: $57,738
Hematology & Oncology $57,738
Vivek Abhyankar, Md, MD
Hematology & Oncology — Payments: $53,680
Hematology & Oncology $53,680
Dr. Dean Kirkel, Md, MD
Hematology & Oncology — Payments: $53,593
Hematology & Oncology $53,593